Teva Pharmaceuticals Recalls Clonidine Transdermal System
Teva Pharmaceuticals USA, Inc. has issued a Class II drug recall for Clonidine Transdermal System, USP (0.2 mg/day). The recall is currently listed as ongoing.
Topics
Developing
- 891d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 890d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 890d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 890d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
OpenFDA
“FDA Drug Recall: Teva Pharmaceuticals USA, Inc. Class II Status: Ongoing Product: Clonidine Transdermal System, USP, 0.2 mg/day”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade